FDA keeps Jazz's lung cancer accelerated approval in place—for now—despite failed trial and calls for withdrawal
26th October 2022 Uncategorised 0 FDA keeps Jazz’s lung cancer accelerated approval in place—for now—despite failed trial and calls for withdrawal
aliu
Wed, 10/26/2022 – 14:20
More: FDA keeps Jazz's lung cancer accelerated approval in place—for now—despite failed trial and calls for withdrawal
Source: fierce